Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
IPO was covered throughout the initial range on day one -
The medical equipment company is funding its acquisition of Icelandic peer Kerecis with equity
-
The company’s share price dropped after H2 results
-
A new bull market for growth stocks in the US is giving issuers an opportunity to raise capital
-
Hearing aid maker raised equity to pay off debt after shareholders opposed rights issue
-
Kantonsspital Baden satisfies investor demand for long paper with pick-up
